Quick Answer
Compounded semaglutide costs $149 to $399 per month in 2026 through US-licensed telehealth providers, depending on the form (sublingual or injection), the provider, and the commitment tier.
Brand-name semaglutide by comparison costs $968 to $1,349 per month at cash retail without insurance.
Compounded preparations are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. The price difference reflects production cost, not lower quality at accredited pharmacies.
2026 Compounded Semaglutide Pricing (Real Numbers)
Pricing verified May 2026 against each provider's published pricing page. Re-verify quarterly; telehealth pricing changes frequently. All prices reflect cash pricing without insurance, in USD.
| Provider | Plan | First month | Ongoing | All-inclusive? |
|---|---|---|---|---|
| Majesta Health | Express (sublingual semaglutide) | $149 | $199/month | Yes (physician, medication, shipping, messaging, Month 6 included) |
| Majesta Health | Essential (semaglutide injection) | $179 | $299/month | Yes (same) |
| Hims & Hers | Compounded semaglutide injection | $199 (with 12-month prepay) | $199 to $399/month | Tiered by commitment |
| Ro (Roman) | Compounded semaglutide injection | $149 (longest commitment) | $149 to $299/month | Tiered by commitment |
| Medvi | Compounded semaglutide injection | $179 | $299/month | Single plan structure |
| Henry Meds | Compounded semaglutide | $149 to $297/month | Same | Multiple commitment tiers |
| Calibrate | Coaching + medication bundle | $199/month + $1,649 annual fee | First-month total ~$1,848 | Annual contract required |
For a broader provider-by-provider comparison see our cheapest semaglutide online in 2026 guide.
Brand-Name Comparison
For context, here is what brand-name semaglutide costs in 2026 without insurance:
| Brand | Manufacturer | Cash price per month | Indication |
|---|---|---|---|
| Wegovy | Novo Nordisk | ~$1,349 | FDA-approved for weight loss + (since 2024) cardiovascular risk reduction in adults with CVD and overweight or obesity |
| Ozempic | Novo Nordisk | ~$968 to $1,150 | FDA-approved for type 2 diabetes; often prescribed off-label for weight loss |
| Rybelsus | Novo Nordisk | ~$1,029 | FDA-approved oral semaglutide for type 2 diabetes only |
Manufacturer savings programs:
With commercial insurance coverage, copays for brand-name semaglutide can be as low as $25 to $100 per month when approved (often requires prior authorization with documented BMI and comorbidity criteria).
With no insurance coverage, compounded semaglutide through legitimate US-licensed telehealth is consistently the most affordable real path.
What the Price Should Include
The headline price is only meaningful if you know what is bundled. A $149 plan that bills consultation, shipping, and refills separately can easily cost more than a $179 plan with everything included.
A legitimate $149 to $399 monthly compounded semaglutide plan in 2026 should include:
What should NOT be hidden in the fine print:
Insurance and HSA / FSA Reality (2026)
Commercial insurance almost never covers compounded semaglutide. Coverage for brand-name (Wegovy or Ozempic) is variable, with most weight-loss-indication coverage requiring prior authorization and documented BMI plus comorbidity criteria. Coverage for Ozempic for diabetes is generally broader.
Medicare does not cover GLP-1s for weight loss as of 2026. Medicare Part D covers Ozempic for diabetes indication.
Medicaid varies by state. Many state programs cover GLP-1s for diabetes only.
HSA and FSA cards typically reimburse prescription compounded semaglutide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts.
The All-In Six-Month Math
This is the comparison that matters for cash-paying patients planning treatment.
| Plan | Month 1 | Months 2-5 | Month 6 | Total six-month | Average / month |
|---|---|---|---|---|---|
| Majesta Express (sublingual) | $149 | $199 × 4 = $796 | $0 (included) | $945 | $158 |
| Majesta Essential (injection) | $179 | $299 × 4 = $1,196 | $0 (included) | $1,375 | $229 |
| Other compounded providers (mid-tier $299/mo, no Month 6) | $299 | $299 × 4 = $1,196 | $299 | $1,794 | $299 |
| Calibrate annual program + medication | $1,649 + $199 | $199 × 4 = $796 | $199 | $2,843 | $474 |
| Brand-name Wegovy without insurance | $1,349 | $1,349 × 4 = $5,396 | $1,349 | $8,094 | $1,349 |
The Month 6 medication included benefit on every Majesta plan applies after five consecutive paid monthly cycles (one-time benefit per patient).
Why Pricing Should Not Be the Only Factor
Three factors matter as much as price when evaluating any compounded semaglutide source:
1. Is the prescribing physician real and US-licensed? Cheap sources often skip this. Skipping medical screening is the actual safety risk. 2. Is the dispensing pharmacy accredited? A 503A or 503B pharmacy with NABP accreditation and LegitScript certification, that batch-tests every preparation for potency and sterility, operates at a much higher safety standard than an unaccredited one. 3. Is ongoing physician access included? Side effects and dose adjustments happen for almost every patient in the first 2 to 3 months. Without a physician you can message, you handle them alone.
For a deeper look at how to verify a compounded semaglutide source, see our safety guide.
Red Flags: Pricing Below the Market Floor
Legitimate compounded semaglutide pricing in 2026 has a floor around $100 to $150 per month for ongoing supply. Providers offering ongoing compounded semaglutide below that price are almost always cutting one of these:
None of these are safe paths. They also create real legal risk for the buyer in addition to product quality risk.
The true price floor reflects the real cost of active pharmaceutical ingredient sourcing, accredited pharmacy compounding, batch testing, US physician oversight, and HIPAA-compliant infrastructure. Below that floor, something is being skipped.
The Bottom Line
In 2026, compounded semaglutide costs $149 to $399 per month through US-licensed telehealth providers. Brand-name pricing is roughly 4 to 9 times higher without insurance. With insurance coverage, brand-name copays can compete on math, but coverage for weight loss is patchy and often denied without prior authorization.
The most affordable legitimate compounded semaglutide path in 2026 is sublingual semaglutide at $149 your first month. The most popular plan is semaglutide injection at $179 your first month. Compounded preparations are not FDA-approved as final products; the active pharmaceutical ingredient is FDA-registered.
The number that matters is not the headline. It is the all-in monthly cost at a provider with a real US-licensed physician, an accredited compounding pharmacy, and ongoing physician access included.
If you want a physician-reviewed recommendation specific to your situation, start your 2-minute medical assessment at /quiz. A US-licensed physician will review your information, screen for contraindications, and confirm the right plan for you.
Related guides
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Prices reflect typical 2026 US retail and are subject to change. Individual results may vary.
Frequently Asked Questions
How much does compounded semaglutide cost per month in 2026?
Through US-licensed telehealth providers, compounded semaglutide costs $149 to $399 per month in 2026. Sublingual semaglutide is the most affordable at $149 to $249 per first month. Injection semaglutide ranges from $179 to $399 per month depending on provider and commitment tier. Brand-name Wegovy by comparison is around $1,349 per month at cash retail without insurance.
Why is compounded semaglutide so much cheaper than Wegovy or Ozempic?
Brand-name semaglutide (Wegovy at around $1,349 per month, Ozempic at $968 to $1,150 per month) carries the cost of original Phase 3 clinical trials (STEP program), FDA approval, large-scale industrial manufacturing, and significant marketing spend. Compounded semaglutide uses the same FDA-registered active pharmaceutical ingredient prepared in smaller batches at state-licensed 503A or 503B compounding pharmacies. The pricing reflects production cost without the brand premium. The trade-off is that the compounded preparation itself is not FDA-approved as a final product.
What should be included in the monthly compounded semaglutide price?
The all-in monthly price from a legitimate provider should include: the compounded semaglutide medication itself, the physician consultation and prescription (with any medical consultation fee disclosed upfront), discreet shipping in plain packaging, and ongoing physician messaging access for dose adjustments and side-effect questions. The headline price is only meaningful when these are bundled. A $149 plan that bills consultation, shipping, and messaging separately often costs more all-in than a $179 plan with everything included.
Does insurance cover compounded semaglutide?
Compounded semaglutide is almost never covered by commercial insurance, Medicare, or Medicaid. The trade-off is significantly lower cash pricing compared to brand-name. HSA and FSA cards are typically accepted by US-licensed telehealth providers with a valid prescription. If insurance covers brand-name Wegovy or Zepbound at a low copay (under $200 per month), brand-name often wins on math. Without that coverage, compounded is the most affordable real option.
What hidden fees should I watch for when comparing compounded semaglutide prices?
Watch for separate consultation fees, shipping fees, refill fees, lab work fees, multi-month prepay requirements to access the published cheapest tier, plan cancellation penalties, paid coaching tiers bundled with the medication, and undisclosed dose-escalation upcharges. The legitimate way to compare providers is to compute the total first-month cost including any one-time fees, and the total ongoing monthly cost with no commitment.
Is there a price below which compounded semaglutide becomes unsafe?
Roughly yes. Legitimate cash pricing in 2026 has a floor around $100 to $150 per month. Providers offering ongoing compounded semaglutide below that price are almost always cutting one of three required steps: skipping real medical screening, using an unregulated pharmacy (often offshore), or selling as 'research peptides' without a prescription. Each of those creates real safety and legal risk. The true price floor reflects the real cost of active pharmaceutical ingredient, accredited pharmacy compounding, batch testing, and physician oversight.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)